Page 32 - MemoriaDEM-Eng

HORIZONTAL PROGRAMMES AND PLATFORMS

Vázquez ja, VendRell j. Prevalence of the metabolic syndrome in Spain using regional cutoff
points for waist circumference: the [email protected] study. Acta Diabetol. 2013 Aug;50(4):615-23.

doi: 10.1007/s00592-013-0468-8. Epub 2013 Mar 20. PubMed PMID: 23512475.

• Rojo-MaRtínez G, soRIGueR F, ColoMo n, Calle a, Goday a, boRdIú e, delGado e, Menéndez e, oRteGa
e, u I, G j, C l, C M, G s, V s; [email protected] study group.
RRutIaIRbésastañoataláaztaMbIdealdés
Factors determining high-sensitivity C-reactive protein values in the Spanish population. Di@
bet.es study. Eur J Clin Invest. 2013 Jan;43(1):1-10. doi: 10.1111/eci.12002. Epub 2012 Nov

7. PubMed PMID: 23134526.

• GutIéRRez-RePIso C, Rojo-MaRtínez G, soRIGueR F, GaRCía-Fuentes e, VendRell j, Vázquez ja, Valdés
s, u I, s-R M, P-M G, o e, M-P I, M e, M-
RRutIaeRRanoIosasCualanIChRteGaoRaeCesenéndezaRtínez
laRRad Mt, lóPez-alba a, GutIéRRez G, GoMIs R, Goday a, GIRbés j, GaztaMbIde s, FRanCh j, delGado
e, C M, C C, C l, C R, C R, C-P a, b e, b-C
ataláastellastañoasaMItjanaaRMenaalleasCualoRdIúosChoMas
a. Factors affecting levels of urinary albumin excretion in the general population of Spain: í
the [email protected] study. Clin Sci (Lond). 2013 Feb;124(4):269-77. doi: 10.1042/CS20120261.

PubMed PMID: 22970892.
ó

í

í
PILCHARDUS STUDY

CIBERDEM Project

Status: Development

PILCHARDUS is a clinical research project that aims to test the hypothesis that a sardine-
rich diet can improve metabolic control in patients with type 2 diabetes mellitus.

CIBERDEM is the driving force behind this multicenter study with the participation of

Hospital Clnic de Barcelona as the coordinator and Hospital de la Vall d’Hebrón de Bar-

celona and Hospital Carlos Haya de Málaga as associated centres.
Groups involved: R. Gomis (coordinator), R. Simó, F. Soriguer, A. Novials and X. Correig
à
(Metabolomics Platform).

The objectives of the study are to evaluate the effects of a sardine-rich diet on blood

glucose control, inflammation markers, blood pressure, lipid metabolism and intestinal
microbiota in patients with recently diagnosed type 2 diabetes or patients not under-

going pharmacological treatment.

Sixty-two patients are to be included in the study. They will be randomly divided into

two groups: the intervention group (sardine diet) and the control group (normal diet).
The diet consists of replacing part of the daily protein intake with 100 g of sardines, five

times a week for six months. Canned sardines or sardines processed in other ways are
supplied. The Galician fish-canning company, Cerqueira, collaborated by providing all

the canned sardines required for the study free of charge, and the food research centre 13
20
Fundacin Alcia, led by chef Ferran Adri, designed sardine-based products to provide T
patients with a wide gastronomic variety of sardine-based meals and to prevent mono- R
PO
tonous diets.
E
L R
A
NU
Indicators/results/status
N
A
In 2012 and 2013, informed consent forms for the study and case report forms were /
designed and printed, and the materials needed for carrying out the nutrition education EM
D
sessions were prepared. Also, the sardine-based products developed by the Fundación ER
B
Alcia, which is part of the PILCHARDUS study, were selected and their nutritional content CI
was analyzed.
32